GlassScriptPhysician profile
Hardik J Patel
NPI 1396162525
$1,512.63
in general payments reported to CMS, 2019-2025
12 companies · $34.09 in 2025
The $34.09 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $289 · 2021: $138 · 2022: $207 · 2023: $90.40 · 2024: $122 · 2025: $34.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $496.61 | 2019-2022 | |
| Amgen INC. | $243.50 | 2019-2024 | Repatha |
| Abiomed | $181.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.74 | 2019 | |
| Edwards Lifesciences Corporation | $86.71 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $63.13 | 2019 | |
| Kestra Medical Technology Services, INC. | $54.03 | 2023-2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.19 | 2020-2021 | |
| Heartflow, INC. | $30.00 | 2024 | |
| Boston Scientific Corporation | $28.48 | 2024 | Latitude Communicator Power Supply |
| Csl Behring | $24.41 | 2019 | |
| Cardiovascular Systems INC. | $17.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardik Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.